Cargando…

Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry

BACKGROUND: Sulfatides (ST) are a category of sulfated galactosylceramides (GalCer) that are elevated in many types of cancer including, possibly, ovarian cancer. Previous evidence for elevation of ST in ovarian cancer was based on a colorimetric reagent that does not provide structural details and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, Chen, Yanfeng, Momin, Amin, Shaner, Rebecca, Wang, Elaine, Bowen, Nathan J, Matyunina, Lilya V, Walker, L DeEtte, McDonald, John F, Sullards, M Cameron, Merrill, Alfred H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913985/
https://www.ncbi.nlm.nih.gov/pubmed/20624317
http://dx.doi.org/10.1186/1476-4598-9-186
_version_ 1782184717832945664
author Liu, Ying
Chen, Yanfeng
Momin, Amin
Shaner, Rebecca
Wang, Elaine
Bowen, Nathan J
Matyunina, Lilya V
Walker, L DeEtte
McDonald, John F
Sullards, M Cameron
Merrill, Alfred H
author_facet Liu, Ying
Chen, Yanfeng
Momin, Amin
Shaner, Rebecca
Wang, Elaine
Bowen, Nathan J
Matyunina, Lilya V
Walker, L DeEtte
McDonald, John F
Sullards, M Cameron
Merrill, Alfred H
author_sort Liu, Ying
collection PubMed
description BACKGROUND: Sulfatides (ST) are a category of sulfated galactosylceramides (GalCer) that are elevated in many types of cancer including, possibly, ovarian cancer. Previous evidence for elevation of ST in ovarian cancer was based on a colorimetric reagent that does not provide structural details and can also react with other lipids. Therefore, this study utilized mass spectrometry for a structure-specific and quantitative analysis of the types, amounts, and tissue localization of ST in ovarian cancer, and combined these findings with analysis of mRNAs for the relevant enzymes of ST metabolism to explore possible mechanisms. RESULTS: Analysis of 12 ovarian tissues graded as histologically normal or having epithelial ovarian tumors by liquid chromatography electrospray ionization-tandem mass spectrometry (LC ESI-MS/MS) established that most tumor-bearing tissues have higher amounts of ST. Because ovarian cancer tissues are comprised of many different cell types, histological tissue slices were analyzed by matrix-assisted laser desorption ionization-tissue-imaging MS (MALDI-TIMS). The regions where ST were detected by MALDI-TIMS overlapped with the ovarian epithelial carcinoma as identified by H & E staining and histological scoring. Furthermore, the structures for the most prevalent species observed via MALDI-TIMS (d18:1/C16:0-, d18:1/C24:1- and d18:1/C24:0-ST) were confirmed by MALDI-TIMS/MS, whereas, a neighboring ion(m/z 885.6) that was not tumor specific was identified as a phosphatidylinositol. Microarray analysis of mRNAs collected using laser capture microdissection revealed that expression of GalCer synthase and Gal3ST1 (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) were approximately 11- and 3.5-fold higher, respectively, in the ovarian epithelial carcinoma cells versus normal ovarian stromal tissue, and they were 5- and 2.3-fold higher in comparison with normal surface ovarian epithelial cells, which is a likely explanation for the higher ST. CONCLUSIONS: This study combined transcriptomic and lipidomic approaches to establish that sulfatides are elevated in ovarian cancer and should be evaluated further as factors that might be important in ovarian cancer biology and, possibly, as biomarkers.
format Text
id pubmed-2913985
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29139852010-08-03 Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry Liu, Ying Chen, Yanfeng Momin, Amin Shaner, Rebecca Wang, Elaine Bowen, Nathan J Matyunina, Lilya V Walker, L DeEtte McDonald, John F Sullards, M Cameron Merrill, Alfred H Mol Cancer Research BACKGROUND: Sulfatides (ST) are a category of sulfated galactosylceramides (GalCer) that are elevated in many types of cancer including, possibly, ovarian cancer. Previous evidence for elevation of ST in ovarian cancer was based on a colorimetric reagent that does not provide structural details and can also react with other lipids. Therefore, this study utilized mass spectrometry for a structure-specific and quantitative analysis of the types, amounts, and tissue localization of ST in ovarian cancer, and combined these findings with analysis of mRNAs for the relevant enzymes of ST metabolism to explore possible mechanisms. RESULTS: Analysis of 12 ovarian tissues graded as histologically normal or having epithelial ovarian tumors by liquid chromatography electrospray ionization-tandem mass spectrometry (LC ESI-MS/MS) established that most tumor-bearing tissues have higher amounts of ST. Because ovarian cancer tissues are comprised of many different cell types, histological tissue slices were analyzed by matrix-assisted laser desorption ionization-tissue-imaging MS (MALDI-TIMS). The regions where ST were detected by MALDI-TIMS overlapped with the ovarian epithelial carcinoma as identified by H & E staining and histological scoring. Furthermore, the structures for the most prevalent species observed via MALDI-TIMS (d18:1/C16:0-, d18:1/C24:1- and d18:1/C24:0-ST) were confirmed by MALDI-TIMS/MS, whereas, a neighboring ion(m/z 885.6) that was not tumor specific was identified as a phosphatidylinositol. Microarray analysis of mRNAs collected using laser capture microdissection revealed that expression of GalCer synthase and Gal3ST1 (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) were approximately 11- and 3.5-fold higher, respectively, in the ovarian epithelial carcinoma cells versus normal ovarian stromal tissue, and they were 5- and 2.3-fold higher in comparison with normal surface ovarian epithelial cells, which is a likely explanation for the higher ST. CONCLUSIONS: This study combined transcriptomic and lipidomic approaches to establish that sulfatides are elevated in ovarian cancer and should be evaluated further as factors that might be important in ovarian cancer biology and, possibly, as biomarkers. BioMed Central 2010-07-12 /pmc/articles/PMC2913985/ /pubmed/20624317 http://dx.doi.org/10.1186/1476-4598-9-186 Text en Copyright ©2010 Liu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Liu, Ying
Chen, Yanfeng
Momin, Amin
Shaner, Rebecca
Wang, Elaine
Bowen, Nathan J
Matyunina, Lilya V
Walker, L DeEtte
McDonald, John F
Sullards, M Cameron
Merrill, Alfred H
Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
title Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
title_full Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
title_fullStr Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
title_full_unstemmed Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
title_short Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
title_sort elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913985/
https://www.ncbi.nlm.nih.gov/pubmed/20624317
http://dx.doi.org/10.1186/1476-4598-9-186
work_keys_str_mv AT liuying elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT chenyanfeng elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT mominamin elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT shanerrebecca elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT wangelaine elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT bowennathanj elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT matyuninalilyav elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT walkerldeette elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT mcdonaldjohnf elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT sullardsmcameron elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT merrillalfredh elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry